A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2
Abstract Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge and evade immunity, resulting in breakthrough infections in vaccinated populations. There is an urgent need for the development of vaccines with broad protective effects. In this study, we selected h...
| 出版年: | Signal Transduction and Targeted Therapy |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nature Publishing Group
2024-11-01
|
| オンライン・アクセス: | https://doi.org/10.1038/s41392-024-02007-8 |
